Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)
While estimands do not solve all problems of trial design and interpretation, this new concept will enable trials to be designed more appropriately to obtain relevant information to address the clinical question(s) of interest
It is often associated with the normalization of menstrual cycles and these important results are obtained with very few side effects." Enrico Carmina, Endocrinology Unit, University of Palermo School of Medicine A meta-analysis of randomized controlled trials supports these findings, showing that GLP-1 receptor agonists like semaglutide reduced waist circumference by an average of 2 inches (5.16 cm) and BMI by 2.42 points compared to placebo
While the average results favor tirzepatide, your personal experience may vary
Pursuing activities such as strength training, resistance training, yoga, or Pilates can preserve and build lean mass, which in turn strengthens bones
Cohort 2 Co-occurring anti-diabetic medications were similar between dulaglutide and s.c
